Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiovascular Diseases | 36 | 2025 | 827 | 4.260 |
Why?
|
Myocardial Infarction | 40 | 2018 | 855 | 3.240 |
Why?
|
Acute Coronary Syndrome | 23 | 2021 | 256 | 3.010 |
Why?
|
Risk Factors | 102 | 2025 | 4997 | 2.140 |
Why?
|
Coronary Artery Disease | 23 | 2018 | 266 | 2.130 |
Why?
|
Male | 227 | 2025 | 27478 | 2.010 |
Why?
|
Female | 237 | 2025 | 30797 | 1.970 |
Why?
|
Socioeconomic Factors | 44 | 2020 | 781 | 1.950 |
Why?
|
Hypertension | 24 | 2023 | 600 | 1.880 |
Why?
|
United States | 131 | 2024 | 7491 | 1.870 |
Why?
|
Humans | 310 | 2025 | 59280 | 1.820 |
Why?
|
Quality of Health Care | 13 | 2019 | 519 | 1.770 |
Why?
|
Medicare | 24 | 2020 | 601 | 1.640 |
Why?
|
Middle Aged | 128 | 2024 | 16230 | 1.560 |
Why?
|
Young Adult | 59 | 2025 | 4318 | 1.550 |
Why?
|
Prejudice | 7 | 2020 | 61 | 1.530 |
Why?
|
Adult | 138 | 2025 | 15728 | 1.530 |
Why?
|
Residence Characteristics | 17 | 2025 | 224 | 1.520 |
Why?
|
Smoking | 24 | 2021 | 830 | 1.480 |
Why?
|
Coronary Vessels | 10 | 2024 | 108 | 1.370 |
Why?
|
Aged | 110 | 2023 | 13285 | 1.370 |
Why?
|
Internet | 11 | 2018 | 457 | 1.340 |
Why?
|
Practice Patterns, Physicians' | 14 | 2019 | 712 | 1.310 |
Why?
|
General Surgery | 6 | 2019 | 186 | 1.280 |
Why?
|
Longitudinal Studies | 51 | 2024 | 1224 | 1.270 |
Why?
|
Quality Indicators, Health Care | 13 | 2021 | 328 | 1.260 |
Why?
|
Alcohol Drinking | 9 | 2018 | 299 | 1.250 |
Why?
|
Healthcare Disparities | 11 | 2020 | 330 | 1.240 |
Why?
|
Hospitalization | 20 | 2021 | 1278 | 1.210 |
Why?
|
Coronary Disease | 17 | 2011 | 249 | 1.180 |
Why?
|
Health Services Accessibility | 18 | 2018 | 542 | 1.160 |
Why?
|
Quality of Life | 18 | 2023 | 1108 | 1.160 |
Why?
|
Emergency Medical Services | 5 | 2020 | 249 | 1.100 |
Why?
|
Health Behavior | 12 | 2025 | 473 | 1.090 |
Why?
|
Health Status | 16 | 2024 | 449 | 1.090 |
Why?
|
Obesity | 19 | 2023 | 1189 | 1.070 |
Why?
|
Depression | 16 | 2024 | 857 | 1.060 |
Why?
|
Cohort Studies | 40 | 2024 | 2435 | 1.060 |
Why?
|
Cognition Disorders | 3 | 2017 | 217 | 1.030 |
Why?
|
Surgery Department, Hospital | 4 | 2015 | 20 | 1.030 |
Why?
|
Health Status Disparities | 7 | 2023 | 147 | 1.020 |
Why?
|
Body Mass Index | 22 | 2024 | 891 | 1.020 |
Why?
|
Adolescent | 63 | 2025 | 5914 | 1.020 |
Why?
|
Health Services Research | 19 | 2017 | 270 | 1.020 |
Why?
|
Patient Discharge | 14 | 2021 | 479 | 1.010 |
Why?
|
Poverty | 11 | 2014 | 286 | 0.990 |
Why?
|
Frailty | 6 | 2023 | 125 | 0.990 |
Why?
|
Sex Factors | 26 | 2024 | 959 | 0.970 |
Why?
|
Benchmarking | 10 | 2008 | 135 | 0.970 |
Why?
|
Cognition | 5 | 2022 | 459 | 0.970 |
Why?
|
Atrial Fibrillation | 9 | 2023 | 795 | 0.930 |
Why?
|
Patient Readmission | 9 | 2021 | 417 | 0.930 |
Why?
|
Religion | 3 | 2019 | 33 | 0.930 |
Why?
|
Exercise | 12 | 2024 | 913 | 0.900 |
Why?
|
Guideline Adherence | 8 | 2019 | 295 | 0.890 |
Why?
|
Smoking Cessation | 13 | 2016 | 531 | 0.860 |
Why?
|
Risk Assessment | 27 | 2024 | 1907 | 0.860 |
Why?
|
Prospective Studies | 46 | 2023 | 3095 | 0.860 |
Why?
|
Multivariate Analysis | 24 | 2017 | 926 | 0.790 |
Why?
|
Income | 12 | 2020 | 160 | 0.790 |
Why?
|
Blood Pressure | 15 | 2023 | 519 | 0.790 |
Why?
|
Hospitals | 9 | 2019 | 373 | 0.780 |
Why?
|
Wounds and Injuries | 2 | 2015 | 234 | 0.780 |
Why?
|
Total Quality Management | 9 | 2004 | 58 | 0.770 |
Why?
|
Odds Ratio | 21 | 2021 | 772 | 0.760 |
Why?
|
Logistic Models | 28 | 2021 | 1252 | 0.760 |
Why?
|
Stroke | 10 | 2022 | 1135 | 0.740 |
Why?
|
Angina, Unstable | 4 | 2006 | 58 | 0.740 |
Why?
|
Age Factors | 24 | 2024 | 1518 | 0.710 |
Why?
|
Aged, 80 and over | 42 | 2020 | 5063 | 0.710 |
Why?
|
Patient Selection | 7 | 2011 | 445 | 0.710 |
Why?
|
Interpersonal Relations | 2 | 2020 | 150 | 0.710 |
Why?
|
Surveys and Questionnaires | 27 | 2023 | 2584 | 0.700 |
Why?
|
Cross-Sectional Studies | 36 | 2023 | 2461 | 0.700 |
Why?
|
Life Style | 5 | 2018 | 328 | 0.690 |
Why?
|
Alabama | 26 | 2011 | 82 | 0.690 |
Why?
|
Massachusetts | 20 | 2023 | 2083 | 0.680 |
Why?
|
Insurance, Health | 7 | 2016 | 141 | 0.680 |
Why?
|
Hospital Mortality | 20 | 2019 | 842 | 0.680 |
Why?
|
Emergency Service, Hospital | 8 | 2021 | 1019 | 0.660 |
Why?
|
Time Factors | 30 | 2020 | 3567 | 0.650 |
Why?
|
Colorectal Neoplasms | 6 | 2017 | 253 | 0.650 |
Why?
|
Trauma Centers | 3 | 2015 | 120 | 0.640 |
Why?
|
Georgia | 11 | 2019 | 88 | 0.640 |
Why?
|
Spirituality | 2 | 2019 | 47 | 0.630 |
Why?
|
Hyperlipidemias | 2 | 2016 | 38 | 0.610 |
Why?
|
Bias | 3 | 2018 | 106 | 0.610 |
Why?
|
Incidence | 24 | 2023 | 1232 | 0.610 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 35 | 0.610 |
Why?
|
Peer Review | 1 | 2018 | 25 | 0.590 |
Why?
|
Social Class | 11 | 2019 | 123 | 0.580 |
Why?
|
Education, Distance | 2 | 2009 | 34 | 0.580 |
Why?
|
Marketing of Health Services | 2 | 2011 | 23 | 0.570 |
Why?
|
Communication | 4 | 2018 | 552 | 0.570 |
Why?
|
Educational Status | 13 | 2020 | 271 | 0.570 |
Why?
|
Obstetric Labor, Premature | 2 | 2009 | 33 | 0.560 |
Why?
|
Quality Assurance, Health Care | 7 | 2008 | 246 | 0.550 |
Why?
|
Tobacco Smoking | 1 | 2016 | 19 | 0.540 |
Why?
|
Follow-Up Studies | 30 | 2018 | 2323 | 0.530 |
Why?
|
Medicaid | 5 | 2023 | 335 | 0.530 |
Why?
|
Racism | 4 | 2022 | 81 | 0.520 |
Why?
|
Substance-Related Disorders | 5 | 2021 | 689 | 0.510 |
Why?
|
Survivors | 6 | 2019 | 148 | 0.510 |
Why?
|
Ambulatory Care | 3 | 2015 | 299 | 0.500 |
Why?
|
United States Department of Veterans Affairs | 8 | 2011 | 511 | 0.500 |
Why?
|
Education, Medical, Continuing | 4 | 2011 | 98 | 0.500 |
Why?
|
Depressive Disorder | 5 | 2019 | 291 | 0.500 |
Why?
|
Stress, Psychological | 8 | 2025 | 443 | 0.500 |
Why?
|
Rehabilitation Centers | 1 | 2015 | 11 | 0.490 |
Why?
|
Poverty Areas | 3 | 2014 | 16 | 0.480 |
Why?
|
Hospitals, University | 1 | 2015 | 50 | 0.480 |
Why?
|
Prevalence | 22 | 2024 | 1279 | 0.480 |
Why?
|
Biomarkers | 8 | 2024 | 1205 | 0.480 |
Why?
|
Tracheostomy | 1 | 2015 | 32 | 0.470 |
Why?
|
Comorbidity | 17 | 2020 | 1084 | 0.470 |
Why?
|
Attitude of Health Personnel | 4 | 2023 | 558 | 0.460 |
Why?
|
Skilled Nursing Facilities | 1 | 2015 | 84 | 0.450 |
Why?
|
Diabetes Mellitus | 8 | 2015 | 533 | 0.450 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2010 | 149 | 0.450 |
Why?
|
Heart Diseases | 4 | 2013 | 204 | 0.440 |
Why?
|
Patient Compliance | 8 | 2008 | 371 | 0.440 |
Why?
|
Registries | 11 | 2019 | 802 | 0.440 |
Why?
|
Critical Care | 4 | 2018 | 406 | 0.440 |
Why?
|
Disability Evaluation | 1 | 2014 | 214 | 0.430 |
Why?
|
Coronary Artery Bypass | 8 | 2004 | 273 | 0.420 |
Why?
|
Food Supply | 6 | 2021 | 72 | 0.420 |
Why?
|
Diet | 6 | 2021 | 635 | 0.420 |
Why?
|
Social Environment | 5 | 2017 | 95 | 0.420 |
Why?
|
Ambulatory Care Facilities | 2 | 2011 | 102 | 0.420 |
Why?
|
Retrospective Studies | 26 | 2020 | 5966 | 0.410 |
Why?
|
Medication Adherence | 5 | 2022 | 255 | 0.410 |
Why?
|
Hospital Administration | 1 | 2013 | 41 | 0.410 |
Why?
|
Length of Stay | 3 | 2015 | 765 | 0.410 |
Why?
|
Chest Pain | 4 | 2021 | 85 | 0.410 |
Why?
|
Lung Neoplasms | 3 | 2013 | 545 | 0.400 |
Why?
|
Drug Industry | 2 | 2010 | 40 | 0.400 |
Why?
|
Thrombolytic Therapy | 5 | 2005 | 180 | 0.400 |
Why?
|
Mammography | 5 | 1999 | 272 | 0.400 |
Why?
|
Disabled Persons | 1 | 2014 | 205 | 0.390 |
Why?
|
Chronic Disease | 5 | 2011 | 731 | 0.390 |
Why?
|
Breast Neoplasms | 5 | 2013 | 1126 | 0.390 |
Why?
|
Cause of Death | 5 | 2020 | 200 | 0.390 |
Why?
|
Continuity of Patient Care | 6 | 2014 | 172 | 0.380 |
Why?
|
Physicians | 5 | 2010 | 436 | 0.380 |
Why?
|
Insurance Coverage | 4 | 2006 | 98 | 0.370 |
Why?
|
Appointments and Schedules | 3 | 1999 | 53 | 0.370 |
Why?
|
Consumer Behavior | 2 | 2009 | 35 | 0.370 |
Why?
|
Physicians, Family | 2 | 2009 | 75 | 0.350 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 439 | 0.350 |
Why?
|
Editorial Policies | 1 | 2011 | 53 | 0.350 |
Why?
|
Aftercare | 4 | 2021 | 67 | 0.350 |
Why?
|
Economic Recession | 2 | 2020 | 5 | 0.340 |
Why?
|
Social Determinants of Health | 4 | 2021 | 114 | 0.340 |
Why?
|
Treatment Outcome | 17 | 2018 | 5140 | 0.340 |
Why?
|
C-Reactive Protein | 7 | 2019 | 167 | 0.330 |
Why?
|
Delivery of Health Care | 4 | 2017 | 421 | 0.330 |
Why?
|
Physician-Patient Relations | 7 | 2018 | 386 | 0.330 |
Why?
|
Drug Utilization | 4 | 2017 | 223 | 0.330 |
Why?
|
Non-ST Elevated Myocardial Infarction | 3 | 2018 | 32 | 0.330 |
Why?
|
Medical Assistance | 1 | 2009 | 10 | 0.320 |
Why?
|
Attitude to Health | 3 | 2018 | 275 | 0.320 |
Why?
|
Cardiovascular System | 3 | 2019 | 41 | 0.320 |
Why?
|
Demography | 7 | 2018 | 178 | 0.320 |
Why?
|
Drug Costs | 1 | 2009 | 59 | 0.310 |
Why?
|
Calcinosis | 5 | 2010 | 78 | 0.310 |
Why?
|
Environment | 3 | 2020 | 125 | 0.310 |
Why?
|
Health Personnel | 3 | 2018 | 340 | 0.310 |
Why?
|
Aging | 3 | 2024 | 722 | 0.310 |
Why?
|
ST Elevation Myocardial Infarction | 3 | 2018 | 72 | 0.300 |
Why?
|
Prognosis | 14 | 2022 | 1564 | 0.300 |
Why?
|
Physicians, Primary Care | 1 | 2009 | 72 | 0.300 |
Why?
|
Managed Care Programs | 5 | 2017 | 93 | 0.300 |
Why?
|
Cardiology | 5 | 2017 | 164 | 0.290 |
Why?
|
Cholesterol | 5 | 2021 | 255 | 0.290 |
Why?
|
Pregnancy Outcome | 1 | 2009 | 188 | 0.290 |
Why?
|
Pharmaceutical Preparations | 1 | 2009 | 121 | 0.290 |
Why?
|
Chi-Square Distribution | 8 | 2017 | 403 | 0.290 |
Why?
|
Self Care | 2 | 2018 | 211 | 0.290 |
Why?
|
Patient Satisfaction | 4 | 2010 | 413 | 0.290 |
Why?
|
Insurance Claim Review | 2 | 2015 | 80 | 0.280 |
Why?
|
Antihypertensive Agents | 3 | 2022 | 172 | 0.280 |
Why?
|
Models, Statistical | 7 | 2010 | 306 | 0.280 |
Why?
|
Health Care Reform | 3 | 2014 | 88 | 0.280 |
Why?
|
Tachycardia, Ventricular | 3 | 2018 | 118 | 0.280 |
Why?
|
Vulnerable Populations | 2 | 2017 | 83 | 0.280 |
Why?
|
Medical Audit | 3 | 2004 | 60 | 0.280 |
Why?
|
Education, Continuing | 1 | 2007 | 24 | 0.280 |
Why?
|
Confidence Intervals | 8 | 2010 | 256 | 0.280 |
Why?
|
Anxiety Disorders | 2 | 2018 | 188 | 0.270 |
Why?
|
Data Collection | 8 | 2013 | 384 | 0.270 |
Why?
|
Bioterrorism | 2 | 2007 | 11 | 0.270 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2018 | 739 | 0.270 |
Why?
|
Severity of Illness Index | 10 | 2017 | 1447 | 0.260 |
Why?
|
Fee-for-Service Plans | 4 | 2017 | 67 | 0.260 |
Why?
|
Cardiovascular Agents | 3 | 2017 | 99 | 0.260 |
Why?
|
Research Design | 6 | 2025 | 565 | 0.260 |
Why?
|
Physical Examination | 2 | 2001 | 103 | 0.260 |
Why?
|
Anticoagulants | 5 | 2023 | 485 | 0.260 |
Why?
|
Private Sector | 1 | 2005 | 14 | 0.260 |
Why?
|
Public Sector | 1 | 2005 | 19 | 0.260 |
Why?
|
Health Plan Implementation | 1 | 2006 | 42 | 0.260 |
Why?
|
Urban Health | 5 | 2015 | 43 | 0.260 |
Why?
|
Unemployment | 3 | 2020 | 17 | 0.260 |
Why?
|
Outpatient Clinics, Hospital | 3 | 2011 | 40 | 0.260 |
Why?
|
Tobacco Smoke Pollution | 1 | 2006 | 57 | 0.260 |
Why?
|
Kidney Diseases | 4 | 2011 | 157 | 0.250 |
Why?
|
Patient Education as Topic | 3 | 2018 | 446 | 0.250 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 20 | 0.250 |
Why?
|
Thiazolidinediones | 1 | 2005 | 51 | 0.250 |
Why?
|
Emergency Treatment | 1 | 2005 | 51 | 0.250 |
Why?
|
Glucose Intolerance | 1 | 2006 | 88 | 0.250 |
Why?
|
Fast Foods | 3 | 2016 | 15 | 0.240 |
Why?
|
Urban Population | 6 | 2020 | 182 | 0.240 |
Why?
|
Peer Review, Health Care | 2 | 2003 | 17 | 0.240 |
Why?
|
Medically Uninsured | 4 | 2014 | 40 | 0.240 |
Why?
|
Affective Symptoms | 2 | 2009 | 16 | 0.240 |
Why?
|
Directive Counseling | 1 | 2005 | 39 | 0.240 |
Why?
|
Practice Guidelines as Topic | 5 | 2011 | 704 | 0.240 |
Why?
|
Child Abuse | 3 | 2024 | 87 | 0.240 |
Why?
|
Motor Activity | 3 | 2013 | 342 | 0.240 |
Why?
|
Infant, Low Birth Weight | 1 | 2004 | 58 | 0.240 |
Why?
|
Biomedical Research | 2 | 2017 | 250 | 0.240 |
Why?
|
Waist Circumference | 3 | 2021 | 55 | 0.240 |
Why?
|
Family Practice | 2 | 2003 | 204 | 0.240 |
Why?
|
Survival Rate | 9 | 2018 | 787 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2010 | 666 | 0.230 |
Why?
|
Leadership | 2 | 2023 | 200 | 0.230 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 47 | 0.230 |
Why?
|
Inflammation | 5 | 2015 | 1100 | 0.230 |
Why?
|
Mortality | 4 | 2019 | 159 | 0.230 |
Why?
|
Specialties, Surgical | 2 | 2015 | 44 | 0.220 |
Why?
|
Cardiology Service, Hospital | 3 | 2004 | 16 | 0.220 |
Why?
|
Triglycerides | 4 | 2024 | 242 | 0.220 |
Why?
|
Neoplasms | 5 | 2020 | 1233 | 0.220 |
Why?
|
Algorithms | 5 | 2016 | 986 | 0.220 |
Why?
|
Troponin | 1 | 2003 | 37 | 0.220 |
Why?
|
Social Discrimination | 2 | 2014 | 15 | 0.220 |
Why?
|
Linear Models | 8 | 2017 | 419 | 0.220 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 1024 | 0.220 |
Why?
|
Sex Distribution | 8 | 2017 | 254 | 0.220 |
Why?
|
Frail Elderly | 2 | 2022 | 110 | 0.220 |
Why?
|
Salaries and Fringe Benefits | 1 | 2023 | 36 | 0.220 |
Why?
|
Financing, Personal | 3 | 2011 | 25 | 0.220 |
Why?
|
Patient Transfer | 2 | 2018 | 93 | 0.220 |
Why?
|
Prediabetic State | 1 | 2024 | 52 | 0.210 |
Why?
|
Overweight | 2 | 2017 | 247 | 0.210 |
Why?
|
Health Care Surveys | 8 | 2018 | 278 | 0.210 |
Why?
|
Venous Thromboembolism | 2 | 2015 | 139 | 0.210 |
Why?
|
Drug Prescriptions | 5 | 2010 | 188 | 0.210 |
Why?
|
Heart Failure | 8 | 2020 | 861 | 0.210 |
Why?
|
Community Health Services | 2 | 2012 | 128 | 0.210 |
Why?
|
Emergencies | 2 | 2020 | 114 | 0.210 |
Why?
|
Weight Gain | 3 | 2012 | 161 | 0.210 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2009 | 202 | 0.210 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 59 | 0.210 |
Why?
|
Ventricular Function, Left | 3 | 2020 | 262 | 0.210 |
Why?
|
DNA Methylation | 1 | 2024 | 274 | 0.200 |
Why?
|
Transportation of Patients | 2 | 2018 | 42 | 0.200 |
Why?
|
Anthrax | 1 | 2002 | 13 | 0.200 |
Why?
|
Geriatric Assessment | 2 | 2020 | 161 | 0.200 |
Why?
|
Medical Laboratory Science | 1 | 2001 | 9 | 0.200 |
Why?
|
Risk Adjustment | 4 | 2013 | 91 | 0.200 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 50 | 0.190 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 144 | 0.190 |
Why?
|
Hematologic Tests | 1 | 2001 | 14 | 0.190 |
Why?
|
Blood Glucose | 5 | 2021 | 470 | 0.190 |
Why?
|
Emotions | 1 | 2003 | 217 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 326 | 0.190 |
Why?
|
Thoracic Neoplasms | 1 | 2021 | 12 | 0.180 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 350 | 0.180 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2022 | 53 | 0.180 |
Why?
|
Multicenter Studies as Topic | 4 | 2016 | 115 | 0.180 |
Why?
|
Tobacco Use Cessation | 2 | 2013 | 30 | 0.180 |
Why?
|
Extremities | 1 | 2021 | 50 | 0.180 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 32 | 0.180 |
Why?
|
Mental Health | 2 | 2018 | 348 | 0.180 |
Why?
|
Cost-Benefit Analysis | 3 | 2017 | 287 | 0.180 |
Why?
|
Patients | 2 | 2012 | 102 | 0.180 |
Why?
|
Bibliometrics | 1 | 2020 | 27 | 0.180 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2000 | 145 | 0.180 |
Why?
|
Coffee | 1 | 2020 | 19 | 0.180 |
Why?
|
Mohs Surgery | 1 | 2021 | 52 | 0.170 |
Why?
|
Mortality, Premature | 1 | 2020 | 6 | 0.170 |
Why?
|
Fatigue | 2 | 2012 | 104 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 4 | 0.170 |
Why?
|
Reminder Systems | 2 | 2011 | 72 | 0.170 |
Why?
|
Anxiety | 5 | 2024 | 395 | 0.170 |
Why?
|
Hospitals, Veterans | 5 | 2005 | 158 | 0.170 |
Why?
|
Ventricular Function, Right | 1 | 2020 | 27 | 0.170 |
Why?
|
Program Development | 3 | 2018 | 210 | 0.170 |
Why?
|
Organizational Objectives | 2 | 2017 | 58 | 0.170 |
Why?
|
Puerto Rico | 3 | 2025 | 227 | 0.170 |
Why?
|
Life Change Events | 2 | 2011 | 66 | 0.170 |
Why?
|
Prescription Drug Misuse | 1 | 2019 | 22 | 0.170 |
Why?
|
Primary Health Care | 5 | 2007 | 645 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2017 | 152 | 0.170 |
Why?
|
Career Choice | 2 | 2017 | 110 | 0.170 |
Why?
|
Religion and Medicine | 1 | 2019 | 22 | 0.170 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 47 | 0.170 |
Why?
|
Patient Participation | 2 | 2019 | 209 | 0.170 |
Why?
|
Health Surveys | 9 | 2016 | 306 | 0.170 |
Why?
|
Social Support | 5 | 2021 | 357 | 0.160 |
Why?
|
Internship and Residency | 4 | 2009 | 721 | 0.160 |
Why?
|
Musculoskeletal Diseases | 1 | 2020 | 101 | 0.160 |
Why?
|
Smokers | 1 | 2020 | 108 | 0.160 |
Why?
|
Life Expectancy | 2 | 2016 | 32 | 0.160 |
Why?
|
Utilization Review | 1 | 1999 | 31 | 0.160 |
Why?
|
Health Care Rationing | 1 | 1999 | 21 | 0.160 |
Why?
|
Cigarette Smoking | 1 | 2019 | 52 | 0.160 |
Why?
|
Smoking Prevention | 2 | 2015 | 162 | 0.160 |
Why?
|
Vaccination | 1 | 2001 | 337 | 0.160 |
Why?
|
Population Surveillance | 4 | 2014 | 205 | 0.160 |
Why?
|
Economics | 1 | 2018 | 7 | 0.160 |
Why?
|
Osteoarthritis | 1 | 2020 | 129 | 0.160 |
Why?
|
Age Distribution | 6 | 2017 | 261 | 0.150 |
Why?
|
Mobile Applications | 1 | 2020 | 130 | 0.150 |
Why?
|
Administration, Oral | 1 | 2019 | 345 | 0.150 |
Why?
|
Kidney Failure, Chronic | 3 | 2011 | 189 | 0.150 |
Why?
|
Medical Indigency | 2 | 1998 | 6 | 0.150 |
Why?
|
Papanicolaou Test | 1 | 1998 | 40 | 0.150 |
Why?
|
Vaginal Smears | 1 | 1998 | 52 | 0.150 |
Why?
|
Consumer Health Information | 1 | 2018 | 33 | 0.150 |
Why?
|
Pregnancy | 4 | 2024 | 2352 | 0.150 |
Why?
|
Communication Barriers | 1 | 2018 | 56 | 0.150 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2017 | 12 | 0.150 |
Why?
|
Fibrinolytic Agents | 3 | 2006 | 164 | 0.150 |
Why?
|
Obesity, Abdominal | 1 | 2017 | 14 | 0.150 |
Why?
|
Marijuana Use | 1 | 2017 | 15 | 0.150 |
Why?
|
Cholesterol, HDL | 2 | 2016 | 78 | 0.150 |
Why?
|
Ventricular Fibrillation | 1 | 2018 | 99 | 0.150 |
Why?
|
Hyperglycemia | 1 | 2018 | 103 | 0.150 |
Why?
|
Heart Rate | 3 | 2016 | 304 | 0.150 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2003 | 141 | 0.150 |
Why?
|
Financing, Organized | 1 | 2017 | 16 | 0.150 |
Why?
|
Professional-Family Relations | 1 | 2018 | 87 | 0.150 |
Why?
|
Employment | 1 | 2019 | 136 | 0.150 |
Why?
|
Forecasting | 3 | 2013 | 221 | 0.150 |
Why?
|
Intra-Abdominal Fat | 1 | 2017 | 40 | 0.140 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 142 | 0.140 |
Why?
|
Social Segregation | 1 | 2017 | 10 | 0.140 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2019 | 152 | 0.140 |
Why?
|
Deficiency Diseases | 1 | 2017 | 12 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2017 | 24 | 0.140 |
Why?
|
Iodine | 1 | 2017 | 21 | 0.140 |
Why?
|
Radiology | 1 | 2021 | 230 | 0.140 |
Why?
|
Cooperative Behavior | 2 | 2013 | 219 | 0.140 |
Why?
|
Diet, Mediterranean | 1 | 2017 | 32 | 0.140 |
Why?
|
Melanoma | 1 | 2021 | 334 | 0.140 |
Why?
|
Creatinine | 4 | 2016 | 121 | 0.140 |
Why?
|
Reproducibility of Results | 7 | 2015 | 1546 | 0.140 |
Why?
|
Self-Management | 1 | 2018 | 61 | 0.140 |
Why?
|
Patient Admission | 1 | 2018 | 185 | 0.140 |
Why?
|
Skin Pigmentation | 2 | 2007 | 32 | 0.140 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 72 | 0.140 |
Why?
|
Alcoholism | 2 | 2010 | 306 | 0.140 |
Why?
|
Mentoring | 1 | 2017 | 48 | 0.140 |
Why?
|
Patient Reported Outcome Measures | 1 | 2017 | 117 | 0.140 |
Why?
|
Sleep Wake Disorders | 2 | 2015 | 68 | 0.140 |
Why?
|
Mentors | 1 | 2017 | 117 | 0.140 |
Why?
|
Venous Thrombosis | 2 | 2015 | 105 | 0.140 |
Why?
|
Medical Records | 3 | 2005 | 137 | 0.130 |
Why?
|
Accountable Care Organizations | 1 | 2017 | 57 | 0.130 |
Why?
|
Interdisciplinary Communication | 2 | 2017 | 106 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 399 | 0.130 |
Why?
|
Health Services Needs and Demand | 3 | 2009 | 214 | 0.130 |
Why?
|
Patient Credit and Collection | 1 | 2016 | 5 | 0.130 |
Why?
|
Hypolipidemic Agents | 1 | 2016 | 33 | 0.130 |
Why?
|
Perception | 2 | 2015 | 178 | 0.130 |
Why?
|
Health Education | 1 | 2017 | 184 | 0.130 |
Why?
|
Survival Analysis | 9 | 2018 | 553 | 0.130 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 384 | 0.130 |
Why?
|
Caregivers | 1 | 2018 | 216 | 0.130 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 105 | 0.130 |
Why?
|
Inpatients | 2 | 2015 | 295 | 0.130 |
Why?
|
Psychosocial Deprivation | 1 | 2015 | 7 | 0.130 |
Why?
|
Psychotherapy, Rational-Emotive | 1 | 2015 | 3 | 0.130 |
Why?
|
Mass Screening | 6 | 2007 | 643 | 0.130 |
Why?
|
Proportional Hazards Models | 7 | 2017 | 672 | 0.130 |
Why?
|
Hemorrhage | 4 | 2022 | 276 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2021 | 403 | 0.130 |
Why?
|
Cognitive Dysfunction | 1 | 2019 | 261 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2017 | 204 | 0.130 |
Why?
|
Child | 7 | 2024 | 4298 | 0.130 |
Why?
|
Psychometrics | 3 | 2014 | 355 | 0.130 |
Why?
|
Marriage | 1 | 2015 | 25 | 0.130 |
Why?
|
Adaptation, Psychological | 3 | 2019 | 263 | 0.120 |
Why?
|
Multiple Chronic Conditions | 1 | 2015 | 33 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2015 | 169 | 0.120 |
Why?
|
Analysis of Variance | 6 | 2002 | 576 | 0.120 |
Why?
|
Social Isolation | 1 | 2015 | 28 | 0.120 |
Why?
|
Program Evaluation | 5 | 2013 | 483 | 0.120 |
Why?
|
Statistics as Topic | 5 | 2017 | 147 | 0.120 |
Why?
|
Chlamydia trachomatis | 2 | 2005 | 57 | 0.120 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 493 | 0.120 |
Why?
|
Infant, Newborn | 3 | 2009 | 1311 | 0.120 |
Why?
|
Parents | 2 | 2015 | 379 | 0.120 |
Why?
|
Chlamydia Infections | 2 | 2005 | 77 | 0.120 |
Why?
|
Specialization | 2 | 2013 | 73 | 0.120 |
Why?
|
Clinical Competence | 3 | 2009 | 676 | 0.120 |
Why?
|
Social Behavior | 1 | 2015 | 88 | 0.120 |
Why?
|
Wounds, Penetrating | 1 | 2014 | 28 | 0.110 |
Why?
|
Disease Management | 1 | 2015 | 220 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 720 | 0.110 |
Why?
|
Food Services | 1 | 2013 | 28 | 0.110 |
Why?
|
Interviews as Topic | 2 | 2013 | 483 | 0.110 |
Why?
|
Drug Therapy | 1 | 1994 | 61 | 0.110 |
Why?
|
Mental Disorders | 1 | 2021 | 763 | 0.110 |
Why?
|
Commerce | 1 | 2014 | 60 | 0.110 |
Why?
|
Social Perception | 1 | 2013 | 36 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2013 | 14 | 0.110 |
Why?
|
General Practice, Dental | 1 | 2013 | 6 | 0.110 |
Why?
|
Cardiac Catheterization | 2 | 2006 | 240 | 0.110 |
Why?
|
Evidence-Based Medicine | 4 | 2006 | 456 | 0.110 |
Why?
|
Hospital Charges | 1 | 2013 | 23 | 0.110 |
Why?
|
Dental Health Services | 1 | 2012 | 14 | 0.100 |
Why?
|
Decision Making | 4 | 2011 | 387 | 0.100 |
Why?
|
Metabolic Syndrome | 2 | 2005 | 150 | 0.100 |
Why?
|
Community-Based Participatory Research | 1 | 2013 | 46 | 0.100 |
Why?
|
Self Efficacy | 1 | 2014 | 201 | 0.100 |
Why?
|
Medical Oncology | 1 | 2013 | 56 | 0.100 |
Why?
|
Body Weight | 2 | 2014 | 378 | 0.100 |
Why?
|
Behavior Therapy | 2 | 2011 | 161 | 0.100 |
Why?
|
Models, Biological | 2 | 2016 | 1138 | 0.100 |
Why?
|
Risk | 5 | 2015 | 371 | 0.100 |
Why?
|
Acute Disease | 3 | 2018 | 658 | 0.100 |
Why?
|
Mouth Neoplasms | 2 | 2010 | 31 | 0.100 |
Why?
|
Recurrence | 4 | 2015 | 576 | 0.100 |
Why?
|
Dentistry | 2 | 2008 | 9 | 0.100 |
Why?
|
California | 3 | 2011 | 160 | 0.100 |
Why?
|
Internal Medicine | 3 | 2009 | 148 | 0.100 |
Why?
|
Population Groups | 1 | 2011 | 12 | 0.090 |
Why?
|
Restaurants | 1 | 2011 | 28 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2003 | 165 | 0.090 |
Why?
|
Longevity | 2 | 2024 | 111 | 0.090 |
Why?
|
Health Promotion | 3 | 2015 | 491 | 0.090 |
Why?
|
Videodisc Recording | 1 | 2011 | 8 | 0.090 |
Why?
|
Health Status Indicators | 2 | 2010 | 98 | 0.090 |
Why?
|
Curriculum | 4 | 2017 | 549 | 0.090 |
Why?
|
Adenocarcinoma | 2 | 2009 | 322 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2011 | 23 | 0.090 |
Why?
|
Electrocardiography | 3 | 2012 | 523 | 0.090 |
Why?
|
Hospitals, Urban | 2 | 2008 | 44 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2015 | 446 | 0.090 |
Why?
|
Vegetables | 1 | 2011 | 91 | 0.090 |
Why?
|
Multimorbidity | 2 | 2021 | 38 | 0.090 |
Why?
|
Teaching | 2 | 2009 | 154 | 0.090 |
Why?
|
Fruit | 1 | 2011 | 121 | 0.090 |
Why?
|
Uric Acid | 1 | 2010 | 49 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2015 | 147 | 0.090 |
Why?
|
Tunica Media | 1 | 2010 | 5 | 0.090 |
Why?
|
Tunica Intima | 1 | 2010 | 14 | 0.090 |
Why?
|
Self Report | 3 | 2020 | 366 | 0.090 |
Why?
|
Radiography | 2 | 2021 | 505 | 0.090 |
Why?
|
Carotid Artery, Common | 1 | 2010 | 30 | 0.090 |
Why?
|
Thyrotropin | 1 | 1990 | 33 | 0.090 |
Why?
|
Data Interpretation, Statistical | 3 | 2001 | 196 | 0.090 |
Why?
|
Models, Organizational | 2 | 2018 | 92 | 0.090 |
Why?
|
Erythrocyte Indices | 1 | 1990 | 4 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 82 | 0.090 |
Why?
|
Insulin | 2 | 2006 | 687 | 0.090 |
Why?
|
Physical Fitness | 2 | 2008 | 92 | 0.090 |
Why?
|
Oral Hygiene | 1 | 2010 | 9 | 0.090 |
Why?
|
Feedback | 2 | 2001 | 87 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 77 | 0.090 |
Why?
|
Computer-Assisted Instruction | 2 | 2008 | 80 | 0.080 |
Why?
|
Delphi Technique | 1 | 2010 | 83 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2006 | 249 | 0.080 |
Why?
|
Geographic Information Systems | 3 | 2015 | 21 | 0.080 |
Why?
|
Electronic Mail | 1 | 2010 | 45 | 0.080 |
Why?
|
Waist-Hip Ratio | 2 | 2006 | 14 | 0.080 |
Why?
|
Pharmacies | 1 | 2009 | 36 | 0.080 |
Why?
|
Databases, Factual | 4 | 2015 | 837 | 0.080 |
Why?
|
Dyslipidemias | 3 | 2015 | 34 | 0.080 |
Why?
|
Body Image | 1 | 2009 | 28 | 0.080 |
Why?
|
Thyroid Diseases | 1 | 1989 | 26 | 0.080 |
Why?
|
Hernia, Ventral | 2 | 2005 | 26 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 675 | 0.080 |
Why?
|
Professional-Patient Relations | 1 | 2009 | 127 | 0.080 |
Why?
|
Education, Medical | 2 | 2009 | 175 | 0.080 |
Why?
|
Hospitals, Rural | 1 | 2008 | 21 | 0.080 |
Why?
|
Practice Patterns, Dentists' | 1 | 2008 | 10 | 0.080 |
Why?
|
Counseling | 4 | 2016 | 351 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2011 | 172 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 134 | 0.080 |
Why?
|
Occupational Health | 1 | 2010 | 186 | 0.080 |
Why?
|
Probability | 4 | 2010 | 172 | 0.070 |
Why?
|
Pharmacists | 1 | 2009 | 123 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2010 | 264 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2009 | 233 | 0.070 |
Why?
|
Regression Analysis | 5 | 2014 | 485 | 0.070 |
Why?
|
Hostility | 2 | 2005 | 17 | 0.070 |
Why?
|
Prenatal Care | 1 | 2009 | 180 | 0.070 |
Why?
|
Family | 2 | 2006 | 219 | 0.070 |
Why?
|
Protective Factors | 2 | 2017 | 34 | 0.070 |
Why?
|
September 11 Terrorist Attacks | 1 | 2007 | 21 | 0.070 |
Why?
|
Prisoners | 1 | 2009 | 166 | 0.070 |
Why?
|
Southeastern United States | 3 | 2013 | 24 | 0.070 |
Why?
|
Faculty, Medical | 1 | 2009 | 202 | 0.070 |
Why?
|
Rural Population | 1 | 2009 | 191 | 0.070 |
Why?
|
Menthol | 1 | 2006 | 5 | 0.070 |
Why?
|
Hospitals, Public | 2 | 1999 | 5 | 0.070 |
Why?
|
Pulmonary Ventilation | 1 | 2006 | 36 | 0.070 |
Why?
|
Quality Improvement | 2 | 2023 | 424 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2019 | 1058 | 0.070 |
Why?
|
Weight Loss | 1 | 2009 | 259 | 0.070 |
Why?
|
Narcotics | 1 | 2006 | 50 | 0.070 |
Why?
|
Patient-Centered Care | 2 | 2020 | 248 | 0.060 |
Why?
|
Observation | 1 | 2005 | 30 | 0.060 |
Why?
|
Chicago | 3 | 2015 | 24 | 0.060 |
Why?
|
Osteoporosis | 1 | 2007 | 137 | 0.060 |
Why?
|
Schools, Medical | 2 | 2009 | 142 | 0.060 |
Why?
|
Health Services for the Aged | 1 | 2006 | 48 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2007 | 151 | 0.060 |
Why?
|
Language | 2 | 2021 | 140 | 0.060 |
Why?
|
Self Disclosure | 1 | 2005 | 37 | 0.060 |
Why?
|
Preventive Medicine | 1 | 2005 | 25 | 0.060 |
Why?
|
Family Health | 1 | 2005 | 68 | 0.060 |
Why?
|
Ethics Committees, Research | 1 | 2005 | 34 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2003 | 1093 | 0.060 |
Why?
|
Hospitals, Community | 1 | 2005 | 71 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2006 | 168 | 0.060 |
Why?
|
Alcoholic Intoxication | 1 | 2005 | 27 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2005 | 68 | 0.060 |
Why?
|
Heparin | 1 | 2006 | 113 | 0.060 |
Why?
|
Cocaine | 1 | 2005 | 86 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2005 | 107 | 0.060 |
Why?
|
Emergency Medicine | 1 | 2007 | 185 | 0.060 |
Why?
|
Glomerular Filtration Rate | 3 | 2011 | 95 | 0.060 |
Why?
|
Birth Order | 1 | 2024 | 3 | 0.060 |
Why?
|
Nursing, Practical | 1 | 2004 | 3 | 0.060 |
Why?
|
Hospitals, Teaching | 2 | 2004 | 102 | 0.060 |
Why?
|
Competitive Behavior | 1 | 2003 | 8 | 0.060 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2000 | 16 | 0.060 |
Why?
|
Mid-Atlantic Region | 1 | 2003 | 2 | 0.060 |
Why?
|
gamma-Glutamyltransferase | 1 | 2003 | 5 | 0.060 |
Why?
|
Research | 1 | 2005 | 191 | 0.060 |
Why?
|
Health Benefit Plans, Employee | 1 | 2003 | 11 | 0.060 |
Why?
|
Nutritional Sciences | 1 | 2003 | 33 | 0.060 |
Why?
|
Cost of Illness | 2 | 2015 | 154 | 0.060 |
Why?
|
Thyroxine | 2 | 1996 | 53 | 0.060 |
Why?
|
Myocardial Ischemia | 1 | 2004 | 108 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2020 | 137 | 0.050 |
Why?
|
Women's Health | 3 | 2000 | 390 | 0.050 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2004 | 71 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 387 | 0.050 |
Why?
|
Medicare Part A | 1 | 2003 | 6 | 0.050 |
Why?
|
Nursing Staff, Hospital | 1 | 2004 | 72 | 0.050 |
Why?
|
Aspirin | 3 | 2004 | 186 | 0.050 |
Why?
|
Risk-Taking | 2 | 2007 | 160 | 0.050 |
Why?
|
Postoperative Complications | 5 | 2001 | 1127 | 0.050 |
Why?
|
Myocardial Reperfusion | 1 | 2002 | 24 | 0.050 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2003 | 59 | 0.050 |
Why?
|
Posture | 1 | 2003 | 126 | 0.050 |
Why?
|
New England | 1 | 2003 | 267 | 0.050 |
Why?
|
Echocardiography | 1 | 2006 | 455 | 0.050 |
Why?
|
Insurance Claim Reporting | 2 | 1999 | 18 | 0.050 |
Why?
|
International Classification of Diseases | 1 | 2003 | 142 | 0.050 |
Why?
|
Dietary Fats | 1 | 2003 | 204 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2002 | 25 | 0.050 |
Why?
|
Referral and Consultation | 2 | 2003 | 408 | 0.050 |
Why?
|
Pain | 3 | 2012 | 406 | 0.050 |
Why?
|
Ofloxacin | 1 | 2002 | 7 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2002 | 9 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2015 | 309 | 0.050 |
Why?
|
Lung Diseases, Obstructive | 1 | 2002 | 20 | 0.050 |
Why?
|
Doxycycline | 1 | 2002 | 41 | 0.050 |
Why?
|
Echocardiography, Doppler | 2 | 2020 | 131 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2002 | 30 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2003 | 227 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2001 | 11 | 0.050 |
Why?
|
Death | 1 | 2001 | 24 | 0.050 |
Why?
|
Cardiopulmonary Bypass | 1 | 2001 | 50 | 0.050 |
Why?
|
Diabetes Complications | 2 | 1999 | 102 | 0.050 |
Why?
|
Vietnam | 2 | 2018 | 160 | 0.050 |
Why?
|
Health Care Costs | 2 | 2017 | 200 | 0.050 |
Why?
|
Dental Research | 2 | 2013 | 10 | 0.050 |
Why?
|
Stroke Volume | 2 | 2020 | 317 | 0.050 |
Why?
|
Glucose | 1 | 2024 | 444 | 0.050 |
Why?
|
Fellowships and Scholarships | 1 | 2002 | 93 | 0.050 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2001 | 85 | 0.050 |
Why?
|
Secondary Prevention | 2 | 2015 | 152 | 0.050 |
Why?
|
SEER Program | 1 | 2021 | 63 | 0.050 |
Why?
|
Intraoperative Care | 1 | 2000 | 36 | 0.050 |
Why?
|
Natural Language Processing | 1 | 2021 | 68 | 0.050 |
Why?
|
Blood Pressure Determination | 2 | 2017 | 43 | 0.040 |
Why?
|
Lipids | 2 | 2018 | 305 | 0.040 |
Why?
|
Tea | 1 | 2020 | 26 | 0.040 |
Why?
|
Influenza Vaccines | 1 | 2001 | 88 | 0.040 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2002 | 114 | 0.040 |
Why?
|
Food Preferences | 2 | 2015 | 55 | 0.040 |
Why?
|
Homicide | 1 | 2020 | 25 | 0.040 |
Why?
|
Bayes Theorem | 2 | 2016 | 108 | 0.040 |
Why?
|
Hyperthyroidism | 2 | 1990 | 17 | 0.040 |
Why?
|
Diuretics | 2 | 2016 | 58 | 0.040 |
Why?
|
History, 21st Century | 1 | 2020 | 161 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2004 | 446 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2019 | 52 | 0.040 |
Why?
|
Disease Progression | 2 | 2018 | 1039 | 0.040 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1999 | 7 | 0.040 |
Why?
|
Uncompensated Care | 1 | 1999 | 5 | 0.040 |
Why?
|
Computer User Training | 1 | 1999 | 7 | 0.040 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 2 | 2012 | 150 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2002 | 303 | 0.040 |
Why?
|
MEDLINE | 1 | 1999 | 19 | 0.040 |
Why?
|
Health Planning Guidelines | 1 | 1999 | 31 | 0.040 |
Why?
|
Health Priorities | 1 | 1999 | 22 | 0.040 |
Why?
|
Opioid-Related Disorders | 1 | 2006 | 465 | 0.040 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 104 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 301 | 0.040 |
Why?
|
Ethanol | 1 | 2022 | 307 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2019 | 90 | 0.040 |
Why?
|
Heart | 2 | 2001 | 274 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 1454 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2020 | 298 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2018 | 94 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 563 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 1999 | 79 | 0.040 |
Why?
|
Fibrinogen | 1 | 1998 | 38 | 0.040 |
Why?
|
Health Maintenance Organizations | 1 | 1998 | 87 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2021 | 350 | 0.040 |
Why?
|
Abdominal Fat | 1 | 2017 | 6 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2019 | 257 | 0.040 |
Why?
|
Rural Health Services | 1 | 2018 | 30 | 0.040 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2017 | 6 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2017 | 22 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2019 | 213 | 0.040 |
Why?
|
Public-Private Sector Partnerships | 1 | 2017 | 11 | 0.040 |
Why?
|
Stakeholder Participation | 1 | 2017 | 22 | 0.040 |
Why?
|
Outpatients | 2 | 2006 | 131 | 0.040 |
Why?
|
Platelet Activation | 1 | 1998 | 89 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2019 | 280 | 0.040 |
Why?
|
Professional Competence | 1 | 2017 | 89 | 0.030 |
Why?
|
Software | 1 | 2000 | 366 | 0.030 |
Why?
|
Research Personnel | 1 | 2017 | 86 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 24 | 0.030 |
Why?
|
Reproductive History | 1 | 2016 | 15 | 0.030 |
Why?
|
Marital Status | 1 | 2016 | 43 | 0.030 |
Why?
|
Insulin Resistance | 2 | 2015 | 403 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2016 | 73 | 0.030 |
Why?
|
Peroxidases | 1 | 1996 | 7 | 0.030 |
Why?
|
Gastric Juice | 1 | 1996 | 8 | 0.030 |
Why?
|
Porphyrins | 1 | 1996 | 7 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2017 | 131 | 0.030 |
Why?
|
Tuberculin Test | 1 | 1996 | 10 | 0.030 |
Why?
|
Hypersensitivity, Delayed | 1 | 1996 | 22 | 0.030 |
Why?
|
Hypothyroidism | 1 | 1996 | 39 | 0.030 |
Why?
|
Minnesota | 2 | 2011 | 37 | 0.030 |
Why?
|
Veterans | 1 | 2004 | 722 | 0.030 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2015 | 13 | 0.030 |
Why?
|
Time | 1 | 2015 | 27 | 0.030 |
Why?
|
Statistics, Nonparametric | 3 | 2001 | 208 | 0.030 |
Why?
|
Fathers | 1 | 1995 | 26 | 0.030 |
Why?
|
Area Under Curve | 1 | 2015 | 128 | 0.030 |
Why?
|
Random Allocation | 1 | 1996 | 198 | 0.030 |
Why?
|
Health Services | 1 | 2016 | 85 | 0.030 |
Why?
|
Minority Groups | 1 | 1997 | 140 | 0.030 |
Why?
|
Family Characteristics | 1 | 2015 | 44 | 0.030 |
Why?
|
Efficiency, Organizational | 1 | 1996 | 95 | 0.030 |
Why?
|
Telemedicine | 1 | 2020 | 333 | 0.030 |
Why?
|
Federal Government | 1 | 1994 | 20 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 51 | 0.030 |
Why?
|
Qualitative Research | 1 | 2018 | 605 | 0.030 |
Why?
|
Iowa | 3 | 1999 | 20 | 0.030 |
Why?
|
Bone Density | 2 | 2007 | 173 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2005 | 113 | 0.030 |
Why?
|
Heart Arrest | 1 | 2016 | 155 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 1994 | 99 | 0.030 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1993 | 8 | 0.030 |
Why?
|
Deductibles and Coinsurance | 1 | 1993 | 8 | 0.030 |
Why?
|
Texas | 1 | 1993 | 54 | 0.030 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 1993 | 3 | 0.030 |
Why?
|
Occupations | 2 | 2005 | 52 | 0.030 |
Why?
|
Liver | 1 | 2017 | 783 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 2013 | 40 | 0.030 |
Why?
|
Tuberculosis | 1 | 1996 | 261 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 1993 | 72 | 0.030 |
Why?
|
Reference Values | 2 | 2006 | 323 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 1993 | 134 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 1993 | 81 | 0.030 |
Why?
|
Behavior | 1 | 2012 | 38 | 0.020 |
Why?
|
Sleep | 1 | 2015 | 218 | 0.020 |
Why?
|
Epitopes | 1 | 1993 | 298 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 158 | 0.020 |
Why?
|
Recovery of Function | 1 | 2013 | 262 | 0.020 |
Why?
|
Exercise Test | 2 | 2008 | 233 | 0.020 |
Why?
|
Albuminuria | 1 | 2011 | 23 | 0.020 |
Why?
|
Prostatic Diseases | 1 | 1991 | 7 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2014 | 314 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1993 | 213 | 0.020 |
Why?
|
Family Relations | 1 | 2011 | 22 | 0.020 |
Why?
|
Prostatectomy | 1 | 1991 | 52 | 0.020 |
Why?
|
Public Policy | 1 | 2011 | 41 | 0.020 |
Why?
|
Mexican Americans | 1 | 2010 | 19 | 0.020 |
Why?
|
Culture | 1 | 2011 | 76 | 0.020 |
Why?
|
Triiodothyronine | 1 | 1990 | 26 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 104 | 0.020 |
Why?
|
Contraindications | 2 | 2002 | 45 | 0.020 |
Why?
|
Professional Review Organizations | 2 | 2001 | 2 | 0.020 |
Why?
|
Social Welfare | 1 | 2010 | 22 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 1993 | 454 | 0.020 |
Why?
|
Nonprescription Drugs | 1 | 2009 | 18 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 281 | 0.020 |
Why?
|
Personality Inventory | 1 | 2009 | 50 | 0.020 |
Why?
|
Arthritis | 1 | 2009 | 49 | 0.020 |
Why?
|
Goiter | 1 | 1989 | 9 | 0.020 |
Why?
|
Child of Impaired Parents | 1 | 2009 | 28 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1989 | 51 | 0.020 |
Why?
|
Prescription Drugs | 1 | 2009 | 50 | 0.020 |
Why?
|
Models, Psychological | 1 | 2009 | 92 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1989 | 116 | 0.020 |
Why?
|
Models, Educational | 1 | 2009 | 63 | 0.020 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 24 | 0.020 |
Why?
|
Education, Dental, Continuing | 1 | 2008 | 4 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2009 | 450 | 0.020 |
Why?
|
Parenting | 1 | 2009 | 73 | 0.020 |
Why?
|
Postoperative Care | 2 | 2004 | 112 | 0.020 |
Why?
|
Cities | 1 | 2008 | 25 | 0.020 |
Why?
|
Carrier State | 1 | 1987 | 18 | 0.020 |
Why?
|
Cephalosporins | 1 | 1987 | 16 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 677 | 0.020 |
Why?
|
Prisons | 1 | 2009 | 114 | 0.020 |
Why?
|
Wisconsin | 2 | 1998 | 14 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2008 | 129 | 0.020 |
Why?
|
Patient Care Team | 1 | 2010 | 324 | 0.020 |
Why?
|
Connecticut | 2 | 1998 | 86 | 0.020 |
Why?
|
Pilot Projects | 2 | 2003 | 917 | 0.020 |
Why?
|
Rheumatic Diseases | 1 | 2007 | 41 | 0.020 |
Why?
|
Awareness | 1 | 2007 | 72 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 73 | 0.020 |
Why?
|
Databases as Topic | 1 | 2007 | 53 | 0.020 |
Why?
|
Diphosphonates | 1 | 2007 | 34 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1987 | 113 | 0.020 |
Why?
|
Amphetamine-Related Disorders | 1 | 2006 | 12 | 0.020 |
Why?
|
Marijuana Abuse | 1 | 2006 | 20 | 0.020 |
Why?
|
Social Adjustment | 1 | 2005 | 34 | 0.020 |
Why?
|
Life Tables | 1 | 2005 | 24 | 0.020 |
Why?
|
Accreditation | 1 | 2006 | 69 | 0.020 |
Why?
|
Sampling Studies | 1 | 2005 | 66 | 0.020 |
Why?
|
Peptic Ulcer | 1 | 2005 | 21 | 0.020 |
Why?
|
Cocaine-Related Disorders | 1 | 2006 | 75 | 0.020 |
Why?
|
Training Support | 1 | 2005 | 16 | 0.020 |
Why?
|
Adolescent Health Services | 1 | 2005 | 19 | 0.020 |
Why?
|
Population Density | 1 | 2005 | 12 | 0.020 |
Why?
|
Community Participation | 1 | 2005 | 43 | 0.020 |
Why?
|
Women's Health Services | 1 | 2005 | 31 | 0.020 |
Why?
|
Medicine | 1 | 2005 | 56 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 250 | 0.010 |
Why?
|
Infant | 1 | 1989 | 1527 | 0.010 |
Why?
|
Stereotyping | 1 | 2004 | 18 | 0.010 |
Why?
|
Clinical Enzyme Tests | 1 | 2003 | 8 | 0.010 |
Why?
|
Critical Pathways | 1 | 2004 | 31 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2003 | 29 | 0.010 |
Why?
|
Child, Preschool | 1 | 1989 | 1837 | 0.010 |
Why?
|
Education, Nursing | 1 | 2004 | 41 | 0.010 |
Why?
|
Taste | 1 | 2003 | 32 | 0.010 |
Why?
|
Age of Onset | 1 | 2003 | 173 | 0.010 |
Why?
|
Cultural Diversity | 1 | 2004 | 52 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 279 | 0.010 |
Why?
|
Ambulances | 1 | 2002 | 24 | 0.010 |
Why?
|
Pediatrics | 1 | 2005 | 266 | 0.010 |
Why?
|
Graft Rejection | 1 | 2004 | 257 | 0.010 |
Why?
|
Organizational Affiliation | 1 | 2002 | 4 | 0.010 |
Why?
|
New Hampshire | 1 | 2002 | 42 | 0.010 |
Why?
|
Competency-Based Education | 1 | 2002 | 28 | 0.010 |
Why?
|
Knowledge | 1 | 2002 | 30 | 0.010 |
Why?
|
Angina Pectoris | 1 | 2001 | 36 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2002 | 199 | 0.010 |
Why?
|
ROC Curve | 1 | 2001 | 259 | 0.010 |
Why?
|
Learning | 1 | 2002 | 171 | 0.010 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1999 | 4 | 0.010 |
Why?
|
Morbidity | 1 | 2000 | 106 | 0.010 |
Why?
|
Ventilator Weaning | 1 | 1999 | 17 | 0.010 |
Why?
|
Causality | 1 | 1999 | 56 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1999 | 38 | 0.010 |
Why?
|
Hemodynamics | 1 | 2000 | 232 | 0.010 |
Why?
|
Documentation | 1 | 2000 | 129 | 0.010 |
Why?
|
Subject Headings | 1 | 1999 | 2 | 0.010 |
Why?
|
Postmenopause | 1 | 2000 | 246 | 0.010 |
Why?
|
Clinical Medicine | 1 | 1999 | 16 | 0.010 |
Why?
|
Reoperation | 1 | 1999 | 249 | 0.010 |
Why?
|
Fees and Charges | 1 | 1998 | 18 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 1998 | 45 | 0.010 |
Why?
|
Louisiana | 1 | 1998 | 18 | 0.010 |
Why?
|
India | 1 | 1998 | 156 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1997 | 7 | 0.010 |
Why?
|
Heart Function Tests | 1 | 1996 | 14 | 0.010 |
Why?
|
Benzidines | 1 | 1996 | 1 | 0.010 |
Why?
|
Pepsin A | 1 | 1996 | 6 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1996 | 44 | 0.010 |
Why?
|
Systole | 1 | 1996 | 109 | 0.010 |
Why?
|
Diastole | 1 | 1996 | 89 | 0.010 |
Why?
|
Reference Standards | 1 | 1996 | 61 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 1996 | 74 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 1996 | 100 | 0.010 |
Why?
|
Workplace | 1 | 1997 | 180 | 0.010 |
Why?
|
Refugees | 1 | 1996 | 62 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 139 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1996 | 427 | 0.010 |
Why?
|
Carcinoembryonic Antigen | 1 | 1993 | 32 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1996 | 740 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 1993 | 10 | 0.010 |
Why?
|
Colonic Polyps | 1 | 1993 | 26 | 0.010 |
Why?
|
Vascular Diseases | 1 | 1993 | 69 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1991 | 42 | 0.010 |
Why?
|
Isoenzymes | 1 | 1991 | 134 | 0.010 |
Why?
|
Preoperative Care | 1 | 1991 | 174 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 869 | 0.000 |
Why?
|
Nasal Cavity | 1 | 1987 | 10 | 0.000 |
Why?
|
Staphylococcus aureus | 1 | 1987 | 158 | 0.000 |
Why?
|